Your browser doesn't support javascript.
loading
Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action.
Cooper, Wade; Ray, Sutapa; Aurora, Sheena K; Shrewsbury, Stephen B; Fuller, Christopher; Davies, Greg; Hoekman, John.
Affiliation
  • Cooper W; Headache and Neuropathic Pain Program, University of Michigan, Ann Arbor, Michigan, USA.
  • Ray S; Impel Pharmaceuticals, Seattle, Washington, USA.
  • Aurora SK; Impel Pharmaceuticals, Seattle, Washington, USA.
  • Shrewsbury SB; Impel Pharmaceuticals, Seattle, Washington, USA.
  • Fuller C; Impel Pharmaceuticals, Seattle, Washington, USA.
  • Davies G; Impel Pharmaceuticals, Seattle, Washington, USA.
  • Hoekman J; Impel Pharmaceuticals, Seattle, Washington, USA.
J Aerosol Med Pulm Drug Deliv ; 35(6): 321-332, 2022 12.
Article in En | MEDLINE | ID: mdl-36108289
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dihydroergotamine / Migraine Disorders Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Aerosol Med Pulm Drug Deliv Journal subject: TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dihydroergotamine / Migraine Disorders Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Aerosol Med Pulm Drug Deliv Journal subject: TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: United States